Related Experiment Videos
[Epidemiology of heart disease in diabetes]
1INSERM Unité 258, Villejuif, France.
Insights
Diabetes mellitus significantly increases the risk of severe cardiac complications, including ischemic heart disease and heart failure. Understanding these risks is crucial for managing diabetes and improving patient outcomes.
Area of Science:
- Cardiology
- Endocrinology
- Epidemiology
Context:
- Diabetes mellitus affects 3% of the French population, with type 2 diabetes comprising 85-90% of cases.
- Cardiac complications are the primary threat to survival in diabetic patients.
- Existing data on the incidence and prevalence of these cardiac events in diabetic populations are limited.
Purpose:
- To analyze cardiovascular drug consumption in diabetic and non-diabetic French patients.
- To determine the incidence and prevalence of major cardiac complications in diabetic subjects using large prospective studies.
- To review coronographic severity scores, prognosis post-coronary events, and cardiac autonomic neuropathy prevalence in diabetics.
Summary:
- This review examines cardiovascular drug use and cardiac complication rates in French diabetic patients.
- It analyzes ischemic heart disease, myocardial events, heart failure, and cardiac autonomic neuropathy.
- The study also assesses coronographic severity and prognosis following cardiac events in diabetic versus non-diabetic individuals.
Impact:
- Highlights the significant cardiovascular burden associated with diabetes mellitus.
- Identifies gaps in epidemiological data regarding cardiac complications in diabetes.
- Informs clinical practice and future research priorities for managing cardiovascular risk in diabetic patients.
Abstract:
Diabetes mellitus is a frequent disease--3% of the French population in 1999. Vital prognosis is essentially related to cardiac complications, at least in type 2 diabetic patients, that is 85 to 90% of diabetic subjects. The most frequently observed cardiac complications are symptomatic or silent ischemic coronary disease and myocardial events, followed by heart failure. These complications may also result from cardiac autonomic neuropathy, be manifested by arrhythmia and even lead to sudden death. Data on the prevalence and incidence of these events are scarce, and the epidemiologic characteristics are not the primary aim of publications. This review analyses: cardiovascular drug consumption in French diabetic and non diabetic patients, the incidence and prevalence rates of the most important cardiac complications from some large general prospective studies which included enough diabetic subjects, coronographic severity scores for diabetic and non-diabetic subjects, prognosis following treated coronary events, some prevalence data on cardiac autonomic neuropathy.